Marc Blaustein

Insider Reports History

Location
Somerville, MA
Signature
/s/ Sydney Gaylin, Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marc Blaustein:

Company Role Class Num Shares Value Price $ Report Date Ownership
Finch Therapeutics Group, Inc. Chief Operating Officer Common Stock 27,995 $101,902 $3.64 21 Feb 2023 Direct

Insider Reports Filed by Marc Blaustein

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FNCH Finch Therapeutics Group, Inc. 21 Feb 2023 1 -$1,755 4 Chief Operating Officer 23 Feb 2023, 15:05
FNCH Finch Therapeutics Group, Inc. 21 Oct 2022 1 -$5,054 4 Chief Operating Officer 25 Oct 2022, 16:31
FNCH Finch Therapeutics Group, Inc. 13 Jun 2022 1 $0 4 Chief Operating Officer 15 Jun 2022, 17:06
FNCH Finch Therapeutics Group, Inc. 25 Feb 2022 1 $0 4 Chief Operating Officer 28 Feb 2022, 17:51
FNCH Finch Therapeutics Group, Inc. 08 Sep 2021 1 $0 4 Chief Operating Officer 10 Sep 2021, 16:27
FNCH Finch Therapeutics Group, Inc. 08 Sep 2021 0 $0 3 Chief Operating Officer 10 Sep 2021, 16:23